Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata

    August 2022 in “ JAMA Dermatology ”
    Sophia Reyes-Hadsall, Lara Drake, Jane Han, Karen J. Lee, Guohai Zhou, Arash Mostaghimi, Kathie P. Huang
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Studysummary In this study, patients with alopecia areata indicated a preference for shared decision-making (SDM) with their dermatologists, and those who engaged in SDM reported less decisional regret about their treatment choices.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study involving 1,074 patients with alopecia areata (AA) found that most participants preferred to make treatment decisions collaboratively with their dermatologist through shared decision-making (SDM). The use of SDM was associated with lower decisional regret, particularly when newer treatments like Janus kinase inhibitors were chosen. The survey revealed that when dermatologists explained treatment options and asked for patient preferences, decisional regret decreased. The study suggested that implementing SDM could enhance patient satisfaction and the quality of treatment decisions, and recommended further research to integrate SDM into evolving AA treatment strategies.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results